and Exchange Commission
of Corporation Finance
Request to Withdraw Registration Statement on Form S-1 (File No.
Pursuant to Rule 477 under the Securities Act of
1933, as amended (the “Securities Act”), Bionik
Laboratories Corp. (the “Registrant”) hereby requests
the immediate withdrawal, effective as of the
date hereof or at the earliest practicable date hereafter,
of the Registration Statement on Form
S-1, File No. 333-216159, together with all exhibits and amendments
thereto (the “Registration Statement”). The
Registration Statement was initially filed with the Securities and
Exchange Commission (the “SEC”) on February 22, 2017,
and amended on February 27, 2017.
Registrant is requesting to withdraw the Registration Statement
because it has elected not to pursue the sale of securities
pursuant to the Registration Statement at this time. The Registrant
confirms that no securities were sold in connection with the
offering contemplated by the Registration Statement. Pursuant to
Rule 477(c) under the Securities Act, the Registrant advises the
SEC that the Registrant may undertake a subsequent private offering
in reliance on Rule 155(c) under the Securities Act.
In accordance with Rule 457(p) of the Securities Act, the
Registrant requests that all fees paid to the SEC in connection
with the filing of the Registration Statement be credited for
Please send copies of
the written order granting withdrawal of the Registration Statement
to Stephen E. Fox of
Ruskin Moscou Faltischek, P.C., via email at email@example.com or via
facsimile at (516) 663-6780.
you have any questions regarding this matter, please call counsel
to the Registrant, Stephen E. Fox of Ruskin Moscou Faltischek,
P.C., at (516) 663-6580.
Chairman and Chief Executive Officer